← Leaderboards
Jerzy Szewczyk
Biokier, Inc.
$5,162,999
Attributed
$5,162,999
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2015–24$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,162,999 · 2
By mechanism
R44$4,727,117 · 1
R43$435,882 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Obesity”
- Chanza Baytop · Westat, Inc.$271,217,917
- Judith S. Currier · University Of California Los Angeles$139,907,800
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$137,892,773
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$108,827,660
- Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
- Joseph E Robertson · Oregon Health & Science University$93,739,249
Research focus
ObesityPreventHormonesNutrientPhysiologicalPlasmaGlucagon-Like Peptide 1GlucoseInsulinNon-Insulin-Dependent Diabetes MellitusOralPharmaceutical PreparationsDiabetic RatDesignDoseFundingChronicCathetersDiabetes MellitusClinical ResearchColonInsulin ResistanceOperative Surgical ProceduresRattus
Grant awards (8)
Clinical development of a colon-targeted butyrate tablet to evaluate effects on cholesterol and trimethyl amine oxide in subjects at risk for cardiovascular disease$435,882
R43 · FY2024 · HL · contact PI
Development of an oral therapeutic to mimic the anti-diabetic effects of gastric bypass surgery$999,710
R44 · FY2021 · DK · contact PI
Development of an oral therapeutic to mimic the anti-diabetic effects of gastric bypass surgery$999,795
R44 · FY2020 · DK · contact PI
Development of an oral therapeutic to mimic the anti-diabetic effects of gastric bypass surgery$999,864
R44 · FY2019 · DK · contact PI
Development of an oral therapeutic to mimic the anti-diabetic effects of gastric bypass surgery$250,402
R44 · FY2018 · DK · contact PI
Development of an oral therapeutic to mimic the anti-diabetic effects of gastric bypass surgery$119,990
R44 · FY2018 · DK · contact PI
Development of an oral therapeutic to mimic the anti-diabetic effects of gastric bypass surgery$1,132,870
R44 · FY2017 · DK · contact PI
Development of an oral therapeutic to mimic the anti-diabetic effects of gastric bypass surgery$224,486
R44 · FY2015 · DK · contact PI